"Maybe Valimed's usefulness lies in too narrow a niche market.
Maybe it has critical limitations to where it will never be marketable for broader applications other than it's currently focused niche and the professional market knows it.
Maybe it's usefulness for counterfeit drug use is 95% hype and 5% reality."
A narrow market, yes. Way too narrow to make any money for the shareholders, especially after "management" skims their "fair share" take (LOL) offa the top.
Broader applications? LOL!! The ideas of turning up bad hooch and druggie medical workers are jokes. Counterfeit drugs? Maybe. But it seems that the FDA have very good processes and procedures already in place to identify such. Otherwise, how would they know that there are "possibly" lots of counterfeit drugs out there? The current propaganda about this particular "threat" can possibly be traced back to big drug companies concern about U.S. citizens going outside the U.S. to buy drugs much cheaper.
I doubt that any finding of counterfeit drugs turned up by
Valimed, if any, would be admissable in courts. It could be useful, perhaps, as a quick screener.
You are correct, DEforeDIDDY..as usual.
News 
Market Data 
Discover 
